Sverre Harvei

1.9k total citations
26 papers, 1.5k citations indexed

About

Sverre Harvei is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Sverre Harvei has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Surgery. Recurrent topics in Sverre Harvei's work include Prostate Cancer Diagnosis and Treatment (9 papers), Global Cancer Incidence and Screening (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Sverre Harvei is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (9 papers), Global Cancer Incidence and Screening (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Sverre Harvei collaborates with scholars based in Norway, Sweden and United States. Sverre Harvei's co-authors include Steinar Tretli, Egil Jellum, Sidney J. Cutler, Maurice M. Black, T Mørk, C.R. Freeman, Lars J. Vatten, Øystein Kravdal, Pär Stattin and Matti Hakama and has published in prestigious journals such as Cancer, Journal of neurosurgery and British Journal of Cancer.

In The Last Decade

Sverre Harvei

25 papers receiving 1.4k citations

Peers

Countries citing papers authored by Sverre Harvei

Since Specialization

Citations

This map shows the geographic impact of Sverre Harvei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sverre Harvei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sverre Harvei more than expected).

Fields of papers citing papers by Sverre Harvei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sverre Harvei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sverre Harvei. The network helps show where Sverre Harvei may publish in the future.

Co-authorship network of co-authors of Sverre Harvei

This figure shows the co-authorship network connecting the top 25 collaborators of Sverre Harvei. A scholar is included among the top collaborators of Sverre Harvei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sverre Harvei. Sverre Harvei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High prostate cancer mortality in Norway: Influence of Cancer Registry information? 2005 ·Apmis ·Eivor Hernes, Sverre Harvei, Eystein Glattre, Finn Gjertsen, Sophie D. Fosså	12
2	Increased mortality rates in young and middle-aged patients with malignant germ cell tumours 2004 ·British Journal of Cancer ·Sophie D. Fosså, Nina Aass, Sverre Harvei, Steinar Tretli	63
3	Metabolism of 25‐hydroxyvitamin D₃ may explain the u‐shaped risk curve for prostate cancer 2004 ·International Journal of Cancer ·Pentti Tuohimaa, Leena Tenkanen, Merja Ahonen, Sonja Lumme, Egil Jellum, Göran Hallmans, Pär Stattin, Sverre Harvei, Timo Hakulinen, Tapio Luostarinen, Joakim Dillner, Matti Lehtinen, Matti Hakama	2
4	Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries 2003 ·International Journal of Cancer ·Pentti Tuohimaa, Leena Tenkanen, Merja Ahonen, Sonja Lumme, Egil Jellum, Göran Hallmans, Pär Stattin, Sverre Harvei, Timo Hakulinen, Tapio Luostarinen, Joakim Dillner, Matti Lehtinen, Matti Hakama	334
5	Circulating enterolactone and prostate cancer risk: A Nordic nested case‐control study 2002 ·International Journal of Cancer ·Pär Stattin, Herman Adlercreutz, Leena Tenkanen, Egil Jellum, Sonja Lumme, Göran Hallmans, Sverre Harvei, L Teppo, Katariina Stumpf, Tapio Luostarinen, Matti Lehtinen, Joakim Dillner, Matti Hakama	72
6	Follow‐up of localized prostate cancer, with emphasis on previous undiagnosed incidental cancer 1999 ·British Journal of Urology ·A. Berner, Sverre Harvei, F Skjørten	5
7	[Epidemiology of prostatic cancer]. 1999 ·PubMed ·Sverre Harvei	2
8	Prediagnostic level of fatty acids in serum phospholipids: Ω-3 and Ω-6 fatty acids and the risk of prostate cancer 1997 ·International Journal of Cancer ·Sverre Harvei, Kristian S. Bjerve, Steinar Tretli, Egil Jellum, Trude Eid Robsahm, Lars J. Vatten	143
9	The Importance of Marital and Socioeconomic Status in Incidence and Survival of Prostate Cancer 1997 ·Preventive Medicine ·Sverre Harvei, Øystein Kravdal	66
10	Prostatic intraepithelial neoplasia in surgical resections 1997 ·Cancer ·(unknown), Aasmund Berner, Sverre Harvei, Trude Eid Robsahm, Steinar Tretli	24
11	Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway. 1997 ·PubMed ·Lars J. Vatten, Giske Ursin, Ronald K. Ross, Frank Z. Stanczyk, Rogerio A. Løbo, Sverre Harvei, Egil Jellum	72
12	Quality of prostate cancer data in the Cancer Registry of Norway 1996 ·European Journal of Cancer ·Sverre Harvei, Steinar Tretli, Frøydis Langmark	55
13	Cancer of the prostate in Norway 1957–1991—A descriptive study 1996 ·European Journal of Cancer ·Sverre Harvei, S. Tretli, Frøydis Langmark	14
14	The burden of prostate cancer from diagnosis until death 1995 ·British Journal of Urology ·B Otnes, Sverre Harvei, S.D. Fosså	28
15	Prostatic carcinoma: a multivariate analysis of prognostic factors 1994 ·British Journal of Cancer ·A. Berner, Sverre Harvei, Steinar Tretli, SD Fosså, (unknown)	25
16	Survival after transurethral and transvesical surgery in localized cancer of the prostate, Norway 1957–1981 1993 ·Cancer ·Sverre Harvei, (unknown), S. Tretli, Frøydis Langmark	1
17	Oligodendroglioma: incidence and biological behavior in a defined population 1985 ·Journal of neurosurgery ·Sverre Mørk, Karl-Fredrik Lindegaard, Tore Halvorsen, (unknown), Torfinn Solgaard, Reidulv Hatlevoll, Sverre Harvei, Jeremy C. Ganz	183
18	[Cancer of the uterine cervix in Norway 1953-1982]. 1984 ·PubMed ·Eiliv Lund, Anders Johansen, Sverre Harvei	2
19	Carcinoma of the Tongue in Norway and Wisconsin I. Incidence and Prognosis Related to Sex and Age 1982 ·Acta Radiologica Oncology ·Halvor Vermund, I. O. Brennhovd, Sverre Harvei, Olav Kaalhus, Erik Poppe, Albert L. Wiley	14
20	The prognosis in osteosarcoma: Norwegian national data 1981 ·Cancer ·Sverre Harvei, (unknown)	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact